Related Experiment Videos
Concanavalin A-induced suppressor cell activity in focal glomerular sclerosis
Nephron
|January 1, 1982
Summary
Focal glomerular sclerosis (FGS) patients with nephrotic syndrome show increased suppressor cell activity (SCA). This immune alteration was not observed in FGS patients in remission or chronic proliferative glomerulonephritis (CGN) patients, suggesting a specific role in FGS pathophysiology.
Area of Science:
- Immunology
- Nephrology
- Cell Biology
Background:
- Suppressor cell activity (SCA) plays a crucial role in immune regulation.
- Focal glomerular sclerosis (FGS) is a kidney disease characterized by scarring of glomeruli.
- Understanding immune dysregulation in FGS is vital for disease management.
Purpose of the Study:
- To investigate suppressor cell activity (SCA) in patients with focal glomerular sclerosis (FGS) and chronic proliferative glomerulonephritis (CGN).
- To determine if altered SCA is associated with nephrotic syndrome (NS) in FGS patients.
Main Methods:
- Peripheral blood lymphocytes (PBL) from 8 FGS patients and 11 CGN patients were stimulated with concanavalin A (Con A).
- The ability of stimulated PBL to inhibit the proliferative response of normal allogeneic lymphocytes (stimulated by Con A or phytohemagglutinin (PHA)) was assessed.
- Suppression index was calculated to quantify SCA.
Main Results:
- FGS patients with nephrotic syndrome exhibited significantly increased SCA compared to normal controls.
- PBL from FGS patients in remission showed normal SCA levels.
- CGN patients, with or without NS, also displayed normal SCA, similar to controls.
Conclusions:
- A majority of FGS patients with nephrotic syndrome demonstrate altered Con A-induced SCA.
- This immune alteration may have significance in the pathophysiology of focal glomerular sclerosis.
- Further research is warranted to explore the precise mechanisms and clinical implications of altered SCA in FGS.